Jennifer Kim

Stock Analyst at Cantor Fitzgerald

(2.50)
# 2,253
Out of 4,851 analysts
35
Total ratings
43.59%
Success rate
3.05%
Average return

Stocks Rated by Jennifer Kim

Belite Bio
May 15, 2025
Reiterates: Overweight
Price Target: n/a
Current: $65.03
Upside: -
Precigen
May 15, 2025
Reiterates: Overweight
Price Target: n/a
Current: $1.33
Upside: -
Insmed
Feb 20, 2025
Reiterates: Overweight
Price Target: n/a
Current: $73.69
Upside: -
Fortress Biotech
Jun 20, 2024
Reiterates: Overweight
Price Target: n/a
Current: $1.85
Upside: -
EyePoint Pharmaceuticals
Jun 20, 2024
Reiterates: Overweight
Price Target: n/a
Current: $8.20
Upside: -
Ocugen
Aug 31, 2023
Maintains: Overweight
Price Target: $2.5$2
Current: $0.89
Upside: +125.43%
Lipocine
Jul 27, 2023
Reiterates: Overweight
Price Target: $33
Current: $3.19
Upside: +934.48%
ProQR Therapeutics
May 17, 2023
Maintains: Overweight
Price Target: $5$4.5
Current: $1.81
Upside: +148.62%
Aytu BioPharma
May 17, 2022
Maintains: Overweight
Price Target: $220$100
Current: $1.59
Upside: +6,189.31%